Browse by Speciality Area

Hospital Management
Cardiology
Critical Care
Emergency Medicine
Infectious Disease
Integrative Medicine
Internal Medicine
Neurology
Obstetrics/Gynecology
Primary Care/Hospitalist

Browse by Product Type

Subscription Publications
Books & Study Guides

All Products

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

CardioMind (Sunnyvale, California), an under-the-radar developer of coronary stents, has its eye on a specific, underserved sector of the drug-eluting stent (DES) sector: the worldwide market for vessel "scaffold" devices.

CardioMind launches its study of Sparrow stent Down Under

Name: Relias Media
Price range: $

January 2, 2015

Reprints

How Does the 12-Lead Help?
Xanomeline and Trospium Chloride Capsules (Cobenfy)
A New Technique for Predicting Outcomes in Asymptomatic AS
Antithrombotic Treatment for Atrial Fibrillation After Acute Coronary Events
Screening for Atrial Fibrillation in Older Adults

Post Date: January 2, 2015

Table of Contents

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Subscription Publication

Books & Study Guides

Group & Site Licenses

State CME/CE Requirements